𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Increased messenger RNA from protein synthesis inhibited human fibroblasts

✍ Scribed by L. E. Maroun; E. T. Miller


Publisher
John Wiley and Sons
Year
1977
Tongue
English
Weight
381 KB
Volume
92
Category
Article
ISSN
0021-9541

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

Numerous reports have demonstrated that specific protein synthesis in response to specific inducers is markedly stimulated by a simultaneous brief exposure to protein synthesis inhibitors such as cycloheximide. This phenomenon is known as β€œsuperinduction” and is most often attributed to the accumulation of cytoplasmic messenger RNA during the inhibition period. Messenger RNA, as defined by rapid labeling, oligo (dt)‐cellulose binding, and cell free protein synthesis stimulation was measured in cycloheximide treated human fibroblasts. In spite of a consistent 40% decrease in total polysomal ^3^H‐uridine labeled RNA, a 1.5‐ to 2‐fold increase in extractable mRNA was observed. These data provide direct evidence that protein synthesis inhibition stimulates the appearance of cytoplasmic mRNA and/or completely blocks its degradation and, are consistent with the hypothesis that mRNA accumulation partly underlies the superinduction phenomena.


πŸ“œ SIMILAR VOLUMES


Induction of cyclic AMP synthesis by for
✍ Nils-Erik Heldin; Ylva Paulsson; Karin Forsberg; Carl-Henrik Heldin; Bengt Weste πŸ“‚ Article πŸ“… 1989 πŸ› John Wiley and Sons 🌐 English βš– 785 KB

We have studied the effect of increased intracellular levels of cyclic AMP on the growth response to platelet-derived growth factor (PDGF) of human foreskin fibroblasts in culture. It was found that forskolin, a potent stimulator of adenylate cyclase activity, inhibits the stimulatory effect of PDGF

Small interfering RNA effectively inhibi
✍ Ramesh Prabhu; Padmaja Vittal; Qinyan Yin; Erik Flemington; Robert Garry; Willia πŸ“‚ Article πŸ“… 2005 πŸ› John Wiley and Sons 🌐 English βš– 242 KB πŸ‘ 1 views

## Abstract Hepatitis C virus (HCV) infection is usually treated with the combination of interferon and ribavirin, but only a small fraction of patients develop a sustained remission. There is need for the development of specific molecular approaches for the treatment of chronic HCV infection. We p